Compare Prospect Capital Corporation (PSEC) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prospect Capital Corporation vs uniQure N.V. Ordinary Shares — how do they compare? Prospect Capital Corporation trades at $1.59 (market cap $891.47M), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: uniQure N.V. Ordinary Shares is the larger of the two by market cap, and Prospect Capital Corporation pays a 25.15% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Prospect Capital Corporation for 78 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PSEC | QURE | |
|---|---|---|
Market Cap | $891.47M | $1.48B |
Volume | 4,809,352 | 2,488,780 |
Sector | Financials | Health |
52-Week High | $3.05 | $70.59 |
52-Week Low | $1.60 | $9.03 |
Typical Hold Time | 78 Days | 0 Days |
Enterprise Value | $2.65B | $728.62M |
Dividend Yield | 25.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PSEC trades at $1.60, down 7.51% with bearish technical signals dominating. The stock shows mixed fundamentals with a low P/B ratio of 0.3x but concerning revenue volatility, including a -$407M revenue in 2025. Recent quarterly earnings have consistently beaten expectations, though the company maintains a modest 25% analyst buy rating amid ongoing dividend distributions of $0.04 monthly.
Outlook remains cautious due to negative cash flow and volatile revenue patterns. The 18%+ dividend yield attracts income investors but carries sustainability risks given declining NAV and portfolio contraction. Analyst consensus leans neutral with 55% hold ratings, reflecting concerns about long-term performance stability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
